| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 272, Issue 6 1053-L1058, Copyright © 1997 by American Physiological Society
ARTICLES |
C. G. Irvin, Y. P. Tu, J. R. Sheller and C. D. Funk
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.
To determine the role of 5-lipoxygenase products in the development of airway reactivity that follows antigen exposure, we sensitized mice by intraperitoneal injection of ovalbumin and aluminum hydroxide and serial exposure to aerosols of ovalbumin. Mice lacking a functioning 5-lipoxygenase enzyme were produced by targeted gene disruption. They and their wild-type controls had measurements of lung resistance (RL) made in response to intravenous methacholine; bronchoalveolar lavage fluid cell counts and serum immunoglobulin concentrations were also measured. Wild-type mice developed striking increases in cholinergic responsiveness; 5-lipoxygenase-deficient mice manifested minimal alterations in methacholine responsiveness (RL at the highest methacholine dose was 9.9 +/- 2.4 cmH2O.ml-1.s-1 under control conditions vs. 27.6 +/- 4.6 cmH2O.ml-1.s-1 after ovalbumin in wild-type mice; 5.9 +/- 0.9 vs. 7.01 +/- 2.2 cmH2O.ml-1.s-1 in 5-lipoxygenase-deficient mice). Ovalbumin provoked airway eosinophilia and increased immunoglobulins in wild-type mice, which were present to a significantly lesser degree in 5-lipoxygenase-deficient mice. We conclude that 5-lipoxygenase products are essential for the production of nonspecific airway reactivity in mice and suggest that 5-lipoxygenase products may be important in immunoglobulin formation.
This article has been cited by other articles:
|
|
 |
|
  S. S. Wagers, H. C. Haverkamp, J. H. T. Bates, R. J. Norton, J. A. Thompson-Figueroa, M. J. Sullivan, and C. G. Irvin Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms J Appl Physiol, January 1, 2007; 102(1): 221 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Homma, J. H. T. Bates, and C. G. Irvin Airway hyperresponsiveness induced by cationic proteins in vivo: site of action Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L413 - L418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Yang, A. Haczku, H. Chen, V. Martin, H. Galczenski, Y. Tomer, C. R. Van Beisen, J. F. Evans, R. A. Panettieri, and C. D. Funk Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4 Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L992 - L1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Abraham Of Mice and Men Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Eum, K. Maghni, Q. Hamid, H. Campbell, D. H. Eidelman, and J. G. Martin Involvement of the Cysteinyl-Leukotrienes in Allergen-Induced Airway Eosinophilia and Hyperresponsiveness in the Mouse Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kheradmand, A. Kiss, J. Xu, S.-H. Lee, P. E. Kolattukudy, and D. B. Corry A Protease-Activated Pathway Underlying Th Cell Type 2 Activation and Allergic Lung Disease J. Immunol., November 15, 2002; 169(10): 5904 - 5911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aoki-Nagase, T. Nagase, Y. Oh-hashi, T. Shindo, Y. Kurihara, Y. Yamaguchi, H. Yamamoto, T. Tomita, E. Ohga, R. Nagai, et al. Attenuation of antigen-induced airway hyperresponsiveness in CGRP-deficient mice Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L963 - L970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomioka, J. H. T. Bates, and C. G. Irvin Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations J Appl Physiol, July 1, 2002; 93(1): 263 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Poynter, C. G. Irvin, and Y. M. W. Janssen-Heininger Rapid Activation of Nuclear Factor-{kappa}B in Airway Epithelium in a Murine Model of Allergic Airway Inflammation Am. J. Pathol., April 1, 2002; 160(4): 1325 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Zeldin The 5-Lipoxygenase Pathway . A New Therapeutic Target for the Treatment of Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 146 - 147. [Full Text] [PDF]
|
|
|
|
|
|
D. C. Zeldin, C. Wohlford-Lenane, P. Chulada, J. Alyce Bradbury, P. E. Scarborough, V. Roggli, R. Langenbach, and D. A. Schwartz Airway Inflammation and Responsiveness in Prostaglandin H Synthase-Deficient Mice Exposed to Bacterial Lipopolysaccharide Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 457 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jacobs and D. C. Zeldin The lung HETEs (and EETs) up Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, J. M. Shannon, C. G. Irvin, K. A. Fagan, C. Cool, A. Augustin, and R. J. Mason Overexpression of tumor necrosis factor-{alpha} produces an increase in lung volumes and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, January 1, 2001; 280(1): L39 - L49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. KANEHIRO, K. TAKEDA, A. JOETHAM, A. TOMKINSON, T. IKEMURA, C. G. IRVIN, and E. W. GELFAND Timing of Administration of Anti-VLA-4 Differentiates Airway Hyperresponsiveness in the Central and Peripheral Airways in Mice Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1132 - 1139. [Abstract] [Full Text]
|
|
|
|
|
|
H.-D. Held and S. Uhlig Basal lung mechanics and airway and pulmonary vascular responsiveness in different inbred mouse strains J Appl Physiol, June 1, 2000; 88(6): 2192 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. FUNK and X.-S. CHEN 5-Lipoxygenase and Leukotrienes . Transgenic Mouse and Nuclear Targeting Studies Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S120 - 124. [Full Text] [PDF]
|
|
|
|
|
|
S. T. HOLGATE and A. P. SAMPSON Antileukotriene Therapy . Future Directions Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S147 - 153. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Aronica, A. L. Mora, D. B. Mitchell, P. W. Finn, J. E. Johnson, J. R. Sheller, and M. R. Boothby Preferential Role for NF-{kappa}B/Rel Signaling in the Type 1 But Not Type 2 T Cell-Dependent Immune Response In Vivo J. Immunol., November 1, 1999; 163(9): 5116 - 5124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Youn, J. Chen, S. Goenka, M. A. Aronica, A. L. Mora, V. Correa, J. R. Sheller, and M. Boothby In Vivo Function of an Interleukin 2 Receptor beta Chain (IL-2Rbeta )/IL-4Ralpha Cytokine Receptor Chimera Potentiates Allergic Airway Disease J. Exp. Med., November 16, 1998; 188(10): 1803 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Showell, M. J. Conklyn, R. Alpert, G. P. Hingorani, K. F. Wright, M. A. Smith, E. Stam, E. D. Salter, D. N. Scampoli, S. Meltzer, et al. The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543 J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 946 - 954. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Maekawa, Y. Kanaoka, B. K. Lam, and K. F. Austen Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing PNAS, February 27, 2001; 98(5): 2256 - 2261. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
